Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World.

Le ZhangFangfang ChenShikai GengXiaodong WangLiyang GuYitian LangTing LiShuang Ye

Published in: Journal of inflammation research (2020)

The MTX+HCQ combination was seemingly superior to MTX+LEF in a real-world cohort of Chinese RA patients with inadequate response to methotrexate monotherapy in respect of the efficacy and cost-effectiveness.

Keyphrases

rheumatoid arthritis
high dose
disease activity
ankylosing spondylitis
randomized controlled trial
clinical trial
low dose
combination therapy
systemic lupus erythematosus
systemic sclerosis